Quality and regulatory

BioSerenity is a manufacturer of medical devices and operates in a strict normative and regulatory framework that ethically guides the marketing of our devices.

A standard

is a technical specification, approved by a certification body, where its implementation is not mandatory. It attests the compliance of a product/service/process/system to a set of requirements. Applicable standards to medical devices and particularly to BioSerenity medical devices are the following (non-exhaustive list):

  • EN ISO 13485: 2016 – Medical devices – Quality management systems – Requirements for regulatory purposes
  • EN ISO 14971: 2019 – Medical devices – Application of risk management to medical devices
  • EN 60601-1: 2006 – Medical electrical equipment – Part 1: General requirements for basic safety and essential performance
  • EN 62304: 2006 – Medical device software – Software life cycle processes

A certificate

is a written attestation of compliance with specific requirements.

Regulatory compliance

The regulatory compliance, beyond the certification process, is the adherence to a set of legislative and regulatory provisions as well as standards and good practices, in order to adapt to all the requirements applicable to a sector (quality, materiovigilence, treatment health data). Through its quality management system and Compliance department, BioSerenity ensures compliance with these requirements for the quality, performance, and safety of its products and services.

MDSAP

MDSAP (Medical Device Single Audit Program) is an international program that assess medical devices manufacturers’ Quality Management System for the following five territories: USA, Canada, Brazil, Australia and Japan. This recent program allows certification in one single audit, the quality management system of a company with 5 juridictions, combining the provisions of ISO 13485: 2016 with the specific requirements of the following 5 countries:

  • US Juridictions (21 CFR Part 820)
  • Canadian Juridictions (SOR 98-282)
  • Brazilian Juridictions (RDC 16/2013)
  • Japanese Juridictions (MHLW MO169)
  • Australian Juridictions (Australian Therapeutic Goods Medical Devices Regulations 2002)

BioSerenity has obtained MDSAP certificates with the 5 Juridictions in June 2018. The  MDSAP certificate aims to optimize and accelerate the registration of Bioserenity products in these five countries.

Certificate Certificate

CE Marking

In accordance with the European legislation, any product meeting the definition of medical device must affix the CE marking, certifying compliance with the provisions of European Directive 93/42/EEC, amended by the Directive 2007/47/EC, that will be replaced, by May 2021, by the provisions of Regulation (EU) 2017/745.

BioSerenity products bear the CE marking. This certifies the products’ compliance to a set of harmonized specifications with the provisions of European Directive 93/42/EEC, amended by Directive 2007/47/EC. In order to anticipate its entry into application, BioSerenity has begun a process of compliance with the requirements of the new Regulation (EU) 2017/745.

Among other requirements, the manufacturer is required to have a quality management system by the Directive evaluated according to the harmonized standard (ISO standard) in force.

  • ISO 13485: 2016

BioSerenity’s Quality Management System has been assessed for compliance with the harmonized standard ISO 13485: 2016 – Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes.

Certificat

Neuronaute intended use

The Neuronaute, is a medical device, composed of a garment and an application, recording electrophysiological signals for electroencephalography purposes.

The Neuronaute requires operation by a trained healthcare professional.

The Neuronaute only acquires and displays physiological signals, no claims may be made for the analysis of the acquired signals with respect to accuracy, precision and reliability.

Class IIa medical device

The Neuronaute does not provide a medical diagnosis

Manufactured and distributed by BioSerenity

CE 2797 / Neuronaute cap FDA cleared

The operator should always refer to the operating instructions before using the medical device and should carefully read all instructions to ensure its proper use.

CardioSkin intended use

The Cardioskin, is a medical device, composed of a garment and an application, recording electrophysiological signals for electrocardiography purposes.

Cardioskin is designed to be used by a patient to transmit multiple-lead ECG signal to a physician’s office, hospital or other remote location under medical supervision.

Cardioskin target population is adults

Class IIa medical device

The Cardioskin does not provide a medical diagnosis.

Manufactured by BioSerenity and distributed by BioSerenity and We Health by Servier

CE 2797

The operator should always refer to the operating instructions before using the medical device and should carefully read all instructions to ensure its proper use.

Last update :19 november 2020

 

BioSerenity FFP2 Masks

These BioSerenity FFP2 Masks are recommended for any person seeking protection against liquid and solid particles.

This mask meets the requirements set forth by regulation (EU) 2015/425 and standard EN149:2001+ A1 2009. It was examined by APAVE (notified body number 0082), APAVE SUDEUROPE SAS – CS60193 – 13322 MARSEILLE CEDEX 16 – France

Instruction of useAPAVE Certification | Letter to users

CONNECTING PATIENTS WITH THEIR HEALTHCARE PROVIDERS ANYTIME AND ANYWHERE

One of the leading global providers of remote diagnostic solutions

HEALTHCARE SERVICES RESEARCH & CLINICAL TRIALS

BioSerenity, through its telemedicine subsidiaries, is currently deploying technologists and physicians to perform and interpret electrophysiological evaluations, and to remotely monitor patients.